Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arabidopsis SUMO E3 Ligase SIZ1 Interacts with HDA6 and Negatively Regulates HDA6 Function during Flowering. | Cells | 2021 | 34831226 | PubTator, text mining | PubMed |
| SUMO Interacting Motifs: Structure and Function. | Cells | 2021 | 34831049 | PubTator, text mining | PubMed |
| The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. | Cancers (Basel) | 2021 | 34830854 | PubTator, text mining | PubMed |
| Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. | Sci Immunol | 2021 | 34826259 | PubTator, text mining | PubMed |
| Predicting Human Protein Subcellular Locations by Using a Combination of Network and Function Features. | Front Genet | 2021 | 34804131 | PubTator, text mining | PubMed |
| Role of FRG1 in predicting the overall survivability in cancers using multivariate based optimal model. | Sci Rep | 2021 | 34795329 | PubTator, text mining | PubMed |
| Identification of proximal SUMO-dependent interactors using SUMO-ID. | Nat Commun | 2021 | 34795231 | PubTator, text mining | PubMed |
| Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome. | Front Oncol | 2021 | 34790575 | PubTator, text mining | PubMed |
Cystic Fibrosis Transmembrane Conductance Regulator Folding Mutations Reveal Differences in Corrector Efficacy Linked to Increases in Immature Cystic Fibrosis Transmembrane Conductance Regulator Expression. | Front Physiol | 2021 | 34764878 | PubTator, text mining | PubMed |
| A modular toolbox to generate complex polymeric ubiquitin architectures using orthogonal sortase enzymes. | Nat Commun | 2021 | 34764289 | PubTator, text mining | PubMed |
| Restoration of aged hematopoietic cells by their young counterparts through instructive microvesicles release. | Aging (Albany NY) | 2021 | 34762598 | PubTator, text mining | PubMed |
| Regulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis. | Open Biol | 2021 | 34753319 | PubTator, text mining | PubMed |
| Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus. | Virulence | 2021 | 34747321 | PubTator, text mining | PubMed |
| An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients. | iScience | 2021 | 34746695 | PubTator, text mining | PubMed |
| Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | Nat Commun | 2021 | 34732716 | PubTator, text mining | PubMed |
| Proteomic Profiling Identifies Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANASIM-Associated Proteins in Hypoxia. | mSystems | 2021 | 34726485 | PubTator, text mining | PubMed |
| SENP3 Promotes an Mff-Primed Bcl-x L -Drp1 Interaction Involved in Cell Death Following Ischemia. | Front Cell Dev Biol | 2021 | 34722538 | PubTator, text mining | PubMed |
| Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics. | Cancer Cell Int | 2021 | 34715855 | PubTator, text mining | PubMed |
| RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy. | Elife | 2021 | 34702444 | PubTator, text mining | PubMed |
| Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma. | Front Immunol | 2021 | 34691083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=26